Karen L. Reckamp
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Molecular Biology top 5%
- Cancer Research top 1%
- Immunology top 2%
- Co-authors
- Steven M. DubinettRobert A. FiglinSherven SharmaSumanta K. PalFelicita BaratelliSeok-Chul YangHua YuMariam Dohadwala
- Topics
- Lung Cancer Treatments and Mutations (168 papers)Colorectal Cancer Treatments and Studies (45 papers)Lung Cancer Research Studies (40 papers)
- Journals
- Nucleic Acids ResearchJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesSouth KoreaCanada
In The Last Decade
Karen L. Reckamp
255 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Oncology 4.1k
- Pulmonary and Respiratory Medicine 3.4k
- Molecular Biology 2.4k
- Cancer Research 1.5k
- Immunology 1.4k
Countries citing papers authored by Karen L. Reckamp
This map shows the geographic impact of Karen L. Reckamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen L. Reckamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen L. Reckamp more than expected).
Fields of papers citing papers by Karen L. Reckamp
This network shows the impact of papers produced by Karen L. Reckamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen L. Reckamp. The network helps show where Karen L. Reckamp may publish in the future.
Co-authorship network of co-authors of Karen L. Reckamp
This figure shows the co-authorship network connecting the top 25 collaborators of Karen L. Reckamp. A scholar is included among the top collaborators of Karen L. Reckamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen L. Reckamp. Karen L. Reckamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 14 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 5 | |
| 6 | 2 | |
| 7 | 8 | |
| 8 | 9 | |
| 9 | 5 | |
| 10 | Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non–Small-Cell Lung Cancer Previously Treated With Immunotherapy—Lung-MAP S1800Abreakdown → | 128 |
| 11 | 2 | |
| 12 | Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancerbreakdown → | 408 |
| 13 | 68 | |
| 14 | 33 | |
| 15 | 131 | |
| 16 | 36 | |
| 17 | 93 | |
| 18 | 99 | |
| 19 | 110 | |
| 20 | 55 |
About Karen L. Reckamp
Karen L. Reckamp is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 269 papers that have together received 7.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (168 papers), Colorectal Cancer Treatments and Studies (45 papers) and Lung Cancer Research Studies (40 papers). The work is most often cited by research in Oncology (4.1k citations), Pulmonary and Respiratory Medicine (3.4k citations) and Cancer Research (1.5k citations). Karen L. Reckamp has collaborated with scholars based in United States, South Korea and Canada. Frequent co-authors include Steven M. Dubinett, Robert A. Figlin, Sherven Sharma, Sumanta K. Pal, Felicita Baratelli, Seok-Chul Yang, Hua Yu, Mariam Dohadwala, Kostyantyn Krysan and Natasha B. Leighl. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.